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FIGURE 1. Results of searches and screening processes used to identify appropriate papers. 
PRISMA Flow Diagram (Adapted from Moher et al., 2009).
Studies remaining after the removal of 
duplicates (n=205) 
Abstracts and titles assessed for 
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Total=8 
Articles excluded (n=156) 
Animal studies (n=6) 
Management of ARS 
(n=84), DT`s (n=24), 
SAWS (n=42) 
Studies excluded (n=41): 
Included specialised bloods 
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Not conducted in an acute 
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Literature reviews (n=6) 
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TABLE 1. Literature search strategy 
Search terms  Hospital, general, acute, alcoholic, alcoholism, dependence, 
alcohol addiction, problem drinker, harmful drinker, alcohol 
misuser, alcohol abuser. (Population) 
History, assessment, medical history, drinking history, risk 
assessment, CIWA-Ar, prediction, prediction tools, 
identification, treatment. (Intervention) 
Risk factors, blood, biomarkers, age, blood pressure, pulse, co-
morbidity, drug use, risk tools, detoxification, identification 
tools, prediction, alcohol withdrawal syndrome (AWS), severe 
alcohol withdrawal (SAW),seizure, alcohol related seizures, 
delirium tremens, DT`s. (Outcome) 
Databases searched CINAHL, MEDLINE, MEDLINE in process, Psychinfo, 
Cochrane database of systematic reviews, EMBASE classic and 
EMBASE 
Part of journals searched First stage involved screening of title and abstract for relevance 
and in the second stage, the main text was reviewed against the 
inclusion and exclusion criteria 
Years of search 1989 to 2017 
Language English language only 
Types of studies to be 
included 
Quantitative and qualitative studies 
Inclusion criteria Humans over 16 years of age admitted to a general hospital and 
ICD, DSM or diagnostic coding of ADS, severe AUD, DT`s, 
ARS or AWS 
Exclusion criteria Children and research carried out in mental health/psychiatric 
care environments because psychiatric symptoms can often 
mimic alcohol withdrawal syndrome 
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SEVERE ALCOHOL WITHDRAWAL SYNDROME: REVIEW OF THE 
LITERATURE
ABSTRACT
PURPOSE: This review set out to identify published literature from a general hospital 
setting that may highlight variables implicated in the development of severe alcohol 
withdrawal syndrome (SAWS) in patients who have alcohol dependence syndrome (ADS).
DESIGN/ METHODOLOGY: A systematic literature review was carried out using the 
electronic databases: MEDLINE, Medline in Process, Cinahl, Embase and PsycINFO from 
1989 to 2017. The focus of this search was on English language studies of individuals over 
16 years admitted to general hospital with ADS, delirium tremens (DT`s), alcohol related 
seizure (ARS) or alcohol withdrawal syndrome (AWS). 
FINDINGS: Of the 205 studies screened, eight met the criteria for inclusion. Six studies 
were quantitative retrospective cohort and two were retrospective case-control. Six studies 
investigated risk factors associated with DT`s, one examined SAWS and one alcohol 
kindling. Descriptive analysis was performed to summarize the empirical evidence from 
studies, were twenty two statistically significant risk factors were found; including reason for 
admission to hospital, daily alcohol consumption, previous DT`s and prior ARS. The last two 
factors mentioned appeared in two studies. 
RESEARCH LIMITATIONS: Further research should consider the quality and 
completeness of the alcohol history data and competence of staff generating the data in 
retrospective studies. 





























































Drugs and Alcohol Today
ORIGINALITY/ VALUE: The paper suggests that the factors linked to SAWS development 
from the literature may not fully explain why some individuals who have ADS develop 
SAWS, and others do not.  
KEYWORDS: alcohol, general hospital, delirium tremens, alcohol-related seizures, alcohol 
withdrawal syndrome
PAPER TYPE: literature review
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INTRODUCTION
Alcohol-attributable disease and injury are widespread (Rehm and Imtiaz, 2016). Excessive 
alcohol consumption contributes to approximately 6% of worldwide deaths and over 5% of 
health conditions (World Health Organisation, 2014). In Scotland, 6.5% of all deaths for over 
16s are attributable to alcohol (ScotPHO, 2018). The severity of alcohol use is depicted 
within a spectrum of Alcohol Use Disorders (AUDs). AUD is a generic term used to describe 
a proliferation of outcomes related to alcohol consumption and is considered to be an 
indicator of the physical and psychological harm caused by drinking (Scottish Government, 
2018). 
Even though the term alcohol dependence has been replaced in the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5) (American Psychiatric Association, 2013) most 
individuals who had an alcohol admission t  acute general hospitals were historically 
described as consuming alcohol in this manner (James et al., 2012). Despite the term 
appearing outdated, it is still prevalent in research and practice (Pryce et al., 2017). A 
consequence and risk of drinking dependently then cutting down or ceasing alcohol abruptly, 
is the possibility of developing alcohol withdrawal syndrome (AWS). AWS is characterised 
by a continuum of physical and psychological signs and symptoms, ranging from mild to 
severe and can be life-threatening (Schuckit, 2014). Munchie et al. (2013) describe criteria 
for mild, moderate and severe alcohol withdrawal syndrome (SAWS) that includes alcohol 
related seizures (ARS) and delirium tremens (DT`s). However, there are no tools available to 
stratify SAWS risk as to who requires hospital admission in this patient group, with literature 
lacking agreement (Maldonado et al., 2014). That said, Goodson et al. (2014) in their 
systematic review and meta-analysis identified that a history of ARS, DT`s, low potassium 
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and platelets were associated with SAWS development in individuals who had Alcohol 
Dependence Syndrome (ADS) (NICE, 2011; James et al., 2012). 
Hospitalisation in those with ADS is confounded by a lack of a tool to stratify risk and the 
likelihood of a person who has ADS experiencing SAWS (NICE, 2011). While several 
variables other than DT`s and ARS are associated with SAWS development, they present 
little risk in isolation, with escalation of SAWS heightened with multiple factors (NICE, 
2011). This review aims to identify variables in the published literature that can be studied 
further to develop a risk stratification tool that can predict the outcome of SAWS in order to 
improve the management of patients, thus potentially saving healthcare costs and resources.
METHOD
A comprehensive search strategy was undertaken to identify primary research studies that 
identified routinely collected health data that could predict the risk of SAWS, DT`s and ARS 
in a general hospital population of patients who have ADS. The electronic databases; 
Medline, Medline in Process, CINAHL (Cumulative Index to Nursing and Allied Health 
Literature), Embase and PsycINFO were searched from 1989 to 2017. This starting year was 
selected as it is a seminal date for alcohol withdrawal management with the advent of the 
Clinical Institute Withdrawal Assessment-Alcohol revised (CIWA-Ar) into clinical practice 
(Sullivan et al., 1989). 
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Inclusion criteria
Inclusion in the systematic literature review included human studies in individuals over 16 
years, conducted within a general hospital setting, with ICD, DSM or diagnostic coding of 
ADS, severe Alcohol Use Disorder (AUD), DT`s, ARS or SAWS. Study design included 
quantitative or qualitative approaches, with any method of data collection. Quantitative 
studies using observational or randomised controlled trial methods were included. 
Search terms
The literature search used a combination of keywords associated with clinical and risk factors 
attributed with the development of DT`s, ARS and SAWS. The Patient Intervention 
Comparison Outcome (PICO) (Richardson et al., 1995) framework was utilised to help define 
and concentrate the literature search. The search was limited to English language studies and 
reference lists were reviewed for additional studies. In addition to this, Google scholar and 
the latest editions of the journals Alcohol, Alcohol and Alcoholism, Alcoholism: Clinical and 
Experimental Research, Journal of Studies on Alcohol and Drugs, American Journal of 
Addiction, Drug and Alcohol Today, British Medical Journal and the Lancet were reviewed 
to capture any new articles not available in the bibliographic databases searched. Systematic 
reviews and clinical guidelines will not be included in the review but their reference lists 
were scanned to identify potentially relevant references not retrieved by the database 
searches. Clinical guidelines, epidemiological studies as well as discussion/opinion papers 
were excluded. The literature search strategy is provided in Table 1.  
TABLE 1 ABOUT HERE
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Study design
Quantitative studies were unanimous within the literature and included, primarily 
observational, either from retrospective case notes, retrospective cohort or retrospective case-
control. The primary condition of study participants was an ICD code of alcohol dependence 
or a DSM code of severe AUD. Study participants could also have a diagnostic coding of 
DT`s, ARS or AWS. Secondary or co-morbid conditions were mainly liver cirrhosis or a non-
stated physical illness. The main focus of the studies was the assessment, monitoring and 
treatment of SAWS symptoms. Routinely presented factors associated with SAWS risk and 
prediction risk. 
One reviewer screened the title and abstracts, where available, of bibliographic records 
retrieved by the searches.  Full-text copies of all papers reporting potentially relevant trials 
were retrieved. All of the studies identified for inclusion were reviewed individually by two 
reviewers and to review the literature pool.  Two reviewers agreed on the final list of studies 
for inclusion in the review.  
Data extraction
One reviewer extracted the data from the included studies using a standard data extraction 
form. The initial data extraction form included ADS/ severe AUD classification, 
qualifications of staff undertaking assessment and research, descriptive statistics about the 
study population, any co-morbid physical or mental health, method used, AWS intervention 
and guidance, outcome predictors and limitations of study. This was cross-checked by a 
second reviewer.  Inter-rater reliability was tested on a random sample of 10% of the studies 
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with the wider research team resolving any disagreements. Descriptive analysis of the 
combined findings was performed to summarize the empirical evidence from studies. 
Quality assessment of studies 
The Reporting of studies Conducted using Observational Routinely-collected health Data 
(RECORD) (Benchimol et al., 2015) was utilised to support the quality of studies used in this 
review. RECORD supports evaluation of retrospective studies using routinely collected 
health data to determine’ strengths and weaknesses and facilitate the sound interpretation and 
application of the results (Nicholls et al., 2015). No studies were rejected for low quality.
RESULTS
The initial search identified a total of 853 articles, reducing to 205 after the exclusion of 
duplicates. After title and abstract scanning; one-hundred and fifty six articles were rejected 
(focusing on management of ARS n=84, DT`s n=24, SAWS n=42, animal studies n=6). Full-
text articles were retrieved for the remaining 49 studies and assessed for eligibility against the 
inclusion criteria. The search and screening process is shown in Figure 1 adapted from Moher 
et al. (2009). 
FIGURE 1 ABOUT HERE
Twelve articles were then excluded as they investigated specialised blood results and their 
relationship with ARS. These bloods; homocysteine (HCY), carbohydrate deficient 
transferring (CDT), oxidative DNA and prolactin serum levels are not routinely collected in 
emergency departments. Eleven articles were excluded as they were not conducted within a 
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general hospital, six were not primary research studies, five had no ICD, DSM or diagnostic 
coding of ADS, severe AUD, DT`s, ARS or AWS and seven were not included because 
research in these articles focused primarily on the evaluation of a tool for assessing SAWS 
symptoms. Eight articles were found to fit the inclusion criteria and were incorporated into 
the systematic review. The eight included articles are outlined in Table 2.
TABLE 2 ABOUT HERE
All studies reviewed were quantitative in design and used a retrospective means for collecting 
data using either a retrospective case-control or cohort methodology, in an acute general 
hospital setting. Studies ranged in size from just over 50 participants to nearly 7,000. All but 
one study (Lee et al., 2005) (South Korea) was carried out in Western countries (Germany, 
Spain, France, US). The population studied from the literature was overwhelmingly white 
(68%) and male (88%) with a mean participant age of between 37-55 years. 
Of the eight studies reviewed, six concentrated on the SAWS manifestation of DT`s (Eyer et 
al., 2011; Ferguson et al., 1996; Lee et al., 2005; Lukan et al., 2002; Monte et al., 2010), one 
(Mennecier et al., 2008) analysed factors associated with SAWS and Booth and Blow (1993) 
investigated risk factors and the kindling effect. All studies were retrospective, ranging from 
12 months (Wright et al., 2006; Ferguson et al. 1996; Booth and Blow, 1993) to 108 months 
(Eyer et al., 2011). The majority of studies defined ADS using ICD and DSM except Lukan 
and colleagues (2002) who utilised the trauma registry diagnostic coding in the United States.  
All patients who developed DT`s, SAWS and alcohol kindling had a diagnosis of ADS.  
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Two studies used an alcohol withdrawal symptom tool to identify SAWS. Mennecier et al. 
(2008) suggested SAWS at a Cushman (Cushman et al., 1985) score of greater than or equal 
to eight at the emergency department (p=0.002) and Eyer et al. (2011) associated SAWS with 
a highest Clinical Institute Withdrawal Assessment-Alcohol revised (CIWA-Ar) (Sullivan et 
al., 1989) score above 15 (OR, 1.23: 95% CI, 1.1- 1.4, p<0.001). The Cushman score is used 
to assess the severity of AWS via a number of clinical characteristics such as pulse, systolic 
blood pressure (SBP), respiratory rate and tremor. CIWA-Ar is a validated tool used to assess 
and treat AWS throu h a number of variables, including nausea and vomiting, tremor, 
paroxysmal sweats, anxiety and agitation. While the other studies did not quantify a measure 
of SAWS, they did recognise DT`s in accordance to ICD or DSM classification. Eyer et al. 
(2011) used a symptom-triggered medication regimen and Mennecier et al. (2008) a fixed 
dosing one. Benzodiazepines were the treatment of choice with Booth and Blow (1993) 
incorporating anti-convulsion medication for the prevention of seizures. Interestingly, Monte 
et al. (2010) used ethyl-alcohol as a treatment of choice.
The eight studies (Eyer et al., 2011; Ferguson et al., 1996; Lee et al., 2005; Lukan et al., 
2002; Monte et al., 2010; Mennecier et al., 2008; Booth and Blow, 1993) looking at DT`s, 
SAWS and alcohol kindling investigated the statistical significance of 69 variables, of which 
43 were only present in one study. The number of variables investigated within each study 
ranged from 6 to 32. The demographic variables of interest in the development of DT`s, 
SAWS and alcohol kindling were employment, housing and gender. Race was investigated in 
four studies and Lukan et al. (2002) identified white race as statistically significant in the 
development of DT`s (OR 2.67; 95% CI: 1.44-4.97: p=0.002), though Ferguson et al. (1996), 
Wright et al. (2006) and Mennecier et al. (2008) did not. Seven out of eight studies evaluated 
the relationship between age and the development of DT`s, SAWS and alcohol kindling with 
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the exception of the Mennecier et al. (2008) study. Statistical significance and the 
development of alcohol kindling and DT`s was statistically associated with age in the Booth 
and Blow (1993) (p<0.0001) and Lukan et al. (2002) (p<0.001) studies, although the 
parameters differed.
Six studies evaluated a number of laboratory diagnostic tests in predicting the risk of DT`s, 
SAWS and alcohol kindling (Ferguson et al., 1996; Lee et al., 2005; Wright et al., 2006; 
Mennecier et al., 2008; Monte et al, 2010; Eyer et al., 2011). Only Eyer et al. (2011) 
identified laboratory diagnostic tests as statistically significant; potassium (OR/1mmol; 0.33; 
95% CI: 0.17-0.65: p=0.001) and platelets (OR/100; 0.42; 95% CI: 0.26-0.69: p=0.001) were 
associated with SAWS. The physiological observations of SBP, diastolic blood pressure 
(DBP), pulse rate, Glasgow Coma Scale (GCS) and temperature were investigated in five 
studies (Ferguson et al., 1996; Lukan et al., 2002; Lee et al., 2005; Monte et al, 2010; Eyer et 
al., 2011). Monte et al. (2010) found that at greater than 150 mmHg, SBP was associated 
with DT`s (OR 1.9; 95% CI: 1.1-3.8: p=0.03). In addition, Lee et al. (2005), associated a 
pulse rate greater than 100 beats per minute with the development of DT`s (OR 4.16; 95% 
CI: 2.03-8.51: p<0.0001), whereas Monte et al. (2010) and Eyer et al. (2011) found no 
association. A temperature greater than 38  C was identified as statistically significant in the 
development of DT`s (OR 1.9; 95% CI: 1.05-3.5: p=0.01) in the study by Monte et al. 
(2010).             
The predictability of co-morbidity was evaluated in six studies (Ferguson et al., 1996; Lukan 
et al., 2002; Lee et al., 2005; Mennecier et al., 2008; Monte et al., 2010; Eyer et al., 2011). 
Ferguson et al. (1996) investigated co-morbidity as a single variable and Lee et al. (2005) as 
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acute and chronic illness. The study by Ferguson et al. (1996) reflected co-morbidity as 
statistically significant in the development of DT`s (OR 5.1; 95% CI: 2.07-12.55: p=0.0004), 
Eyer et al. (2011) identified brain lesion as statistically significant (OR 5.8; 95% CI: 2.6-
12.9: p<0.001), whereas Lukan et al. (2002) recognised motor vehicle collision (OR 0.50; 
95% CI: 0.32-0.78: p=0.002) as a factor in safeguarding against DT`s. 
Among the variables associated with problematic alcohol use, the predictability of previous 
DT`s on the outcome of DT`s and SAWS was investigated in five studies (Ferguson et al., 
1996; Lee et al., 2005; Wright et al., 2006; Mennecier et al., 2008; Eyer et al., 2011). A 
history of DT`s was statistically significant in the development of DT`s in the studies by Lee 
et al. (2005) (OR; 3.99; 95% CI: 1.63-9.76: p<0.0001) and Wright et al. (2006) (X²=5.77, 
df=1, p=0.016). The impact of previous SAWS on the outcome of DT`s, SAWS and alcohol 
kindling was evaluated in five studies (Booth and Blow, 1993; Ferguson et al., 1996; 
Mennecier et al., 2008; Monte et al, 2010; Eyer et al., 2011). Booth and Blow (1993) found 
that a history of SAWS was statistically significant in the development of alcohol kindling 
(p<0.001). Booth and Blow (1993) also recognised previous detoxification, and ARS as 
associated with alcohol kindling (p<0.001), whereas Wright et al. (2006) found no 
association between previous detoxification and DT`s (p>0.05). Additionally, Ferguson et al. 
(1996), Monte et al. (2010) and Eyer et al. (2011) recognised no association between a 
history of SAWS and the development of DT`s, while Mennecier et al. (2008) found no 
association between previous SAWS and the development of SAWS. However, previous 
ARS was associated with DT`s in the study by Monte et al. (2010) (OR 2.2; 95% CI: 1.2-3.8: 
p=0.0005) but not in the study by Eyer et al. (2011) or the Mennecier et al. (2008) study of 
SAWS.  
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Variables recognised as the consequence of problematic alcohol use and their association 
with DT`s, SAWS and alcohol kindling showed inconsistency. The quantity of alcohol 
consumed, family history of alcohol use and length of addiction years showed no association 
with DT`s, SAWS and alcohol kindling. Ferguson et al. (1996) identified that time since last 
drink was statistically significant in the development of DT`s (OR 1.3; 95% CI: 1.09-1.61: 
p=0.047), although Lee et al. (2005) and Monte et al. (2010) did not find this link. ARS as a 
reason for admission to hospital, increased the risk of ARS during admission in the study by 
Eyer et al. (2011) (OR, 2.6: 95% CI, 1.4- 4.8, p=0.002), while being admitted with AWS did 
not (Monte et al., 2010; Eyer et al., 2011). Mennecier et al. (2008) recognised that symptoms 
of AWS captured by a Cushman score of greater than or equal to eight in the emergency 
department was associated with the development of SAWS (p=0.002), although Eyer et al. 
(2011) did not find this link with AWS score at the emergency department.
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DISCUSSION
The summary of the empirical evidence and statistical analysis presented by studies in the 
systematic literature review identified 22 variables as statistically significant (Table 2). The 
statistically significant variables included; age, race, co-morbidity, consequence of 
problematic alcohol use, physiological observations and laboratory diagnostic tests, although 
only previous DT`s (Lee et al., 2005; Wright et al., 2006) and ARS (Booth and Blow, 1993; 
Monte et al., 2010) were found in more than one study. Different health databases, variability 
in quality assurance processes and lack of information as to whether data was coded before or 
after upload to the database or at all, within studies might compromise findings (DesRoches 
et al., 2013).  
Demographic data as an indicator of DT`s, SAWS and alcohol kindling risk, was only 
significant for age (Booth and Blow, 1993; Lukan et al., 2002) and race (Lukan et al., 2002). 
Gender showed no association with DT`s, SAWS and alcohol kindling (Monte et al., 2010; 
Eyer et al., 2011), although this review consisted of studies comprising predominantly of 
males. In addition, while Lukan and colleagues (2002) identified white race as associated 
with SAWS, they failed to provide information on whether the comparator was non white or 
different ethnic groups. 
The relationship between age and SAWS was variable in the systematic literature review. 
Although it is assumed that age is an indicator of SAWS risk given that advanced age 
suggests more years of drinking, this was not found in the general hospital population within 
the systematic literature review, but evident in other populations. Booth and Blow (1993) in 
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their study of veterans identified age as statistically significant (p<0.001) in alcohol kindling, 
whereas Wright et al. (2006) in their study of veterans did not find this relationship.  
Nonetheless, it is difficult to discount this relationship in the veteran population when the 
Booth and Blow (1993) study involved a sample of 6,818 from throughout the United States 
of America and Wright et al. (2006) a sample of 56. In addition, problematic alcohol use is 
more prevalent in the military than the general population especially in the event of post 
traumatic stress disorders (PTSD) (Teeter et al., 2017). While the link with older age is also 
evident in the trauma population (Lukan et al., 2002) the population were considerably 
younger and therefore older age set at a lower level (greater than 40 years). A similar finding 
has previously been reported in trauma patients (Parran et al., 1995).   
Uncertainty between co-morbidity and alcohol complications was also evident. Interestingly, 
while the co-morbidity most associated with alcohol use is alcohol liver disease (ALD) 
(NICE, 2011; WHO, 2014), ALD was not a component of most studies in the review. The 
non-inclusion of ALD may be due to a low prevalence within the study populations, while 
liver function tests may be a better measure of acute and chronic liver injury due to alcohol 
use. Nonetheless, liver function blood tests identified similarities between the group who 
developed and did not develop complications of alcohol use. 
The earliest symptoms of AWS are a result of over activity of the autonomic nervous system, 
causing elevation of the physiological markers of SBP, DBP and pulse rate (McKeon et al., 
2008; Carlson et al., 2012). The systematic literature review for the most part failed to 
support this, although when associated with alcohol complication, the recorded observations 
exceed normal levels in the studies by Lee et al. (2005) and Ferguson et al. (1996). The lack 
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of association between physiological markers and SAWS in the reviewed studies may be a 
consequence of unreported confounding factors such as pharmacological intervention. 
Pharmacological intervention for co-morbidity such as hypertension may negate the body’s 
natural response to AWS maintaining a normal blood pressure.
The analysis of whether a history of complicated alcohol events; DT`s, ARS and SAWS were 
a factor in developing future events, like the other results, is inconstant. Alcohol history is 
mainly self-reported and subject to issues of recall, while the terms DT`s and SAWS are often 
misrepresented or over used in the alcohol literature (NICE, 2011; Eyer et al., 2011). In this 
review only previous DT`s and ARS were found to be associated with the development of 
DT`s (Lee et al., 2005; Wright et al., 2006) and ARS (Booth and Blow, 1993; Monte et al., 
2010) in more than one study. 
The studies within the systematic literature review all propose that the patients within the 
studies are subject to an alcohol detoxification and the alcohol kindling theory infers that the 
number of detoxification events increase a person’s risk of SAWS that includes DT`s and 
ARS (Rathlev et al., 2006). However, if detoxification is aimed at reducing the psychological 
trauma and neurological adaptation associated with the need to maintain homeostasis 
(Martinotti, 2009; Heymann et al., 2010), then previous DT`s, ARS and SAWS suggest an 
experience and consequential adaptation (Becker, 2008). Therefore, development of alcohol 
complications in the context of medically assisted detoxifications proposes neurological 
adaptation regardless of symptom amelioration and possible under treatment of the preceding 
AWS (The Royal College of Physicians, 2010). The concept of under treatment is difficult to 
exclude in the Booth and Blow (1993), Lee et al. (2005) and Monte et al. (2010) studies were 





























































Drugs and Alcohol Today
no tools to influence alcohol withdrawal treatment were evident, an omission not found in the 
studies were previous DT`s and ARS were not associated with DT`s and ARS development 
(Mennecier et al., 2008; Eyer et al., 2011). The concept of poor alcohol management in the 
acute hospital is recognised (McKeon et al., 2008; Swift et al., 2010; Sutton and Jutel, 2016) 
and difficult to discount in the systematic literature review where the majority of studies 
investigated DT`s within alcohol detoxification treatment.   
The data collection period within studies ranged from 1-16 years, and the exploration of 
different health databases presented difficulty assuring consistency and quality assurance. 
The studies presented no information on when and if the data abstracted from the databases 
was coded. In addition, no studies presented information on the competence levels of the staff 
that generated the primary data, although poor alcohol assessment in the general hospital 
environment is frequently reported in studies (The Royal College of Physicians, 2010; NICE, 
2011).
While the results presented within the systematic literature review identified a lack of 
consensus in the variables that contributed to alcohol complications, there was consistency in 
the limitations presented by studies. Limitations included; sub-optimal alcohol history, 
missing data, poor SAWS and DT diagnosis, inconsistent treatment and failure to use 
screening and treatment tools. Other than a previous history of DT`s and ARS the systematic 
literature review provided no clarity to other factors that increased the risk of developing 
alcohol complications; DT`s, ARS and alcohol kindling in the acute hospital. However, the 
systematic literature review provided a pool of statistically significant variables from single 
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studies that in combination warrant further investigation in the goal of developing a risk 
stratification tool for AWS.
There are a number of limitations to this review. Although a comprehensive search was 
undertaken, only studies presented in English where included. In addition, the heterogeneous 
nature of studies and definition of variables such as drinking patterns prevented the 
possibility of undertaking a meta-analysis of results. Bias was evident within studies where 
only selected variables from the literature were included, while the retrospective nature of 
studies and use of routinely collected data limited the rigour and generalisability of results. 
Therefore, the extensive variability and lack of commonality in the factors identified as 
significant in the development of alcohol complications requires further exploration. We 
propose that future research into risk variables and alcohol complications should include; 
greater numbers of females, a greater divergence of participant ethnicity, alcohol history data 
captured by clinical experts in alcohol assessment, and investigation of all documented 
statistically significant variables. 
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TABLE 2. Summary table of articles reviewed
Study Study design Intervention 
target (ADS / 
severe AUD 
classification
Number and co-morbid physical / 
psychological health. Place of research
Intervention and 
treatment guidance
Prediction of significance / outcomes
Booth and Blow (1993) Retrospective case 
note review
ICD-9 (n=6,818; males only). 75.4 Caucasian 
75.4%; African American 20.4%; Hispanic 
3%; Native American 1.2%. Data from US 
Veterans Affairs Department. United States.




1. Previous alcohol detoxification (p<0.01). 2. 
Previous SAWS (p<0.001). 3. Previous ARS 
(p<0.001). 4. Older age (p<0.0001) 
Eyer et al., (2011) Retrospective 
cohort study






5. Maximum AWS score during admission 
(OR, 1.23: 95% CI, 1.1- 1.4, P<0.001), 6. 
Presence of structural brain lesion (OR, 6.5: 
95% CI, 3.0- 14.1, p<0.001) 7. ARS as reason 
for admission (OR, 2.6: 95% CI, 1.4- 4.8, 
p=0.002) are associated with risk of ARS.
8. Low potassium (OR, 0.33: 95% CI, 0.17- 
0.65, p=0.001), 9. Low platelets (OR, 0.42: 
95% CI, 0.26- 0.69, p=0.001) 10. Brain lesion 
(OR, 5.8: 95% CI, 2.6- 12.9, p<0.001) are 
associated with an increased risk of DT`s 
Ferguson et al., (1996) Retrospective 
cohort study




11. Concurrent acute medical illness (OR, 
5.1:95% CI, 2.7-12.55, p=0.0004). 12. Two or 
more days since last drink (OR, 1.3:95% CI, 
1.09-1.61 p=0.0047). 
Lee et al., (2005) Retrospective 
cohort study
DSM-IV (n=147: males 95.5%). Physical illness. Benzodiazepines. 
Protocol not specified.
 13 Previous DT`s- (OR, 3.990: 95% CI, 
1.631- 9.759, p=0.002) 14. increased pulse 
rate (OR, 4.158: 95% CI, 2.032- 8.511, 
p<0.0001) associated with risk of DT`s








15. Age>40 years (OR, 2.98: 95% CI, 1.97- 
4.51, p<0.001), 16. White race (OR, 2.67: 
95% CI, 1.44- 4.97, P<0.007), 17. Burn injury 
(OR, 3.63: 95% CI, 1.46- 9.00, p=0.006) 18.  
motor vehicle collision as a negative predictor 
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(OR, 0.50: 95% CI, 0.32- 0.78, p<0.001) are 
associated with risk of DT`s.
Mennecier et al., (2008) Retrospective 
study
DSM-IV (n=182; males 74.7%). Liver cirrhosis and 
alcoholic pancreatopathy. Specialist 
outpatients and emergency department 
referrals to gastroenterology and hepatology 
departments. France.
Diazepam or oxazepam. 
Cushman score.
19. Cushman score ≥8 (P=0.002)
Monte et al., (2008) Retrospective 
cohort study
DSM-IV (n=436; males 91.3%) Physical illness (liver 
cirrhosis, steatohepatitis). University 
teaching hospital. Spain.
Benzodiazepines and 
ethyl alcohol (wine). No 
protocol stated.
3. Previous ARS (OR, 2.2: 95% CI, 1.2- 3.8, 
p=0.005). 20. ≥ 3 (OR, 2.6: 95% CI, 1.04- 6.8, 
p=0.04), 21. Temp>38 ºC (OR, 1.9: 95% CI, 
1.05- 3.5, p=0.03). 22. systolic BP >150 
mmHg (OR, 2.1: 95% CI, 1.1- 3.8, p=0.01) 
associated with a greater risk of DT`s 
Wright et al., (2006) Retrospective 
case-control study
ICD-9 (n=56; males 100%). Caucasians 64.2%; 
African American 32.2%; Native American 




13. Previous DTs (X²=5.77, dof=1, p=0.016)
Page 27 of 27 Drugs and Alcohol Today
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
